forgemax.FORGED. TESTED. PROVEN.
Liquid 50IU 50iu/vial 1 Vial by Imperia Laboratories
Best seller

Liquid 50IU 50iu/vial 1 Vial by Imperia Laboratories

5 (2 reviews)

Imperia Laboratories Liquid 50IU delivers 50 IU of recombinant somatropin per vial, built around the 191-amino-acid primary structure that mirrors endogenous pituitary growth hormone — making molecular authenticity the decisive differentiator over lower-grade 192aa alternatives. Every production batch is evaluated against certified somatropin reference standards using reversed-phase HPLC, with bacterial endotoxin burden confirmed independently through Limulus Amebocyte Lysate (LAL) methodology. Lot-specific purity certificates and analytical records are issued per production batch rather than at product-line level alone.

€150.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Delivers the correct 191-amino-acid somatropin sequence for full GH-receptor binding fidelity
  • HPLC purity profiling confirms ≥98 % target isoform content per released batch
  • LAL endotoxin testing verifies bacterial contamination below pharmacopoeial safety thresholds
  • Batch-specific certificate of analysis traceable to reversed-phase HPLC quantification
  • GMP-sourced API with incoming raw-material certificate review before formulation
  • Single-vial 50 IU format minimises repeated reconstitution exposure, preserving protein integrity
  • Structural authenticity over 192aa variants — reduced immunogenicity risk in extended-use protocols

Key takeaways

  • Verify 191aa sequence confirmation before committing to any extended HGH protocol
  • Demand batch-specific HPLC certificates — lot-level data, not product-level claims
  • Check LAL endotoxin results to rule out pyrogenic contamination risk
  • Distinguish 192aa impurity risk by sourcing from GMP-aligned API suppliers
  • Reconstitute gently and refrigerate promptly to preserve analytical purity post-opening

What Separates Pharmaceutical-Grade Somatropin from Substandard HGH

Imperia Laboratories Liquid 50IU contains recombinant somatropin characterised by the 191-amino-acid chain that exactly mirrors the molecular architecture of naturally secreted pituitary growth hormone — a structural criterion that determines receptor-binding fidelity and downstream IGF-1 expression. The critical quality distinction in the HGH market is not brand name but primary structure: 191aa somatropin folds into the correct three-dimensional conformation required for full GH-receptor occupancy, while 192aa variants — produced when an additional methionine residue is introduced at the N-terminus during prokaryotic expression — carry a structurally altered molecule that elicits a measurably lower biological response and a higher immunogenicity risk, confirmed in comparative receptor-binding assays published in peer-reviewed endocrinology literature.

How Analytical Verification Confirms What a Label Cannot

Reversed-phase HPLC quantifies somatropin content against a certified reference standard, separating the target 22 kDa isoform from degradation products, aggregates and process-related impurities with resolution that visual inspection or bioassay alone cannot provide. HPLC purity profiling detects oxidised methionine variants and deamidated species — both bioactivity-reducing impurities — at concentrations below 1 %, representing the threshold used in the European Pharmacopoeia somatropin monograph. Imperia Laboratories applies this reversed-phase HPLC release gate to every production batch of Liquid 50IU, with the result that each vial's measured API content is traceable to a quantified analytical record rather than a nominal declaration. LAL endotoxin testing provides a parallel quality gate: bacterial endotoxins, a common contaminant in recombinant protein manufacturing, are confirmed below the pharmacopoeial limit of 5 EU per mg of somatropin before any batch is released.

Purity Benchmarks and Why They Matter in Practice

Compared to unverified HGH products circulating in grey markets — where counterfeit testing has identified materials containing as little as 30–60 % of declared somatropin content (source: independent peptide-laboratory analyses published by community testing networks) — a batch-certified 191aa product with confirmed HPLC purity above 98 % delivers predictable dose-response relationships that support structured training and recovery protocols. Imperia Laboratories sources its somatropin API from manufacturers operating within GMP-compliant recombinant protein production frameworks, with raw-material certificates of analysis reviewed at incoming goods inspection prior to formulation. Every vial of Liquid 50IU therefore represents a defined, analytically verified dose — not an estimate.

Usage

  1. Confirm batch documentation first.: Before reconstitution, review the certificate of analysis for HPLC purity (target ≥98 % 22 kDa isoform) and LAL endotoxin result — this is the primary quality check the 191aa designation supports.
  2. Reconstitute with bacteriostatic water.: Add 1–2 ml of bacteriostatic water slowly down the vial wall; never inject the water stream directly onto the lyophilised powder, as mechanical shearing degrades the protein's tertiary structure.
  3. Swirl gently — never vortex.: Rotate the vial between your fingers until the powder is fully dissolved; vortexing introduces aggregates that the HPLC release process cannot correct post-reconstitution.
  4. Use an insulin syringe for subcutaneous administration.: Draw the calculated IU dose into a 29–31 gauge syringe; subcutaneous injection into the abdomen or thigh minimises tissue trauma.
  5. Administer at a consistent time relative to food intake.: Because insulin and GH receptor activity are inversely related, schedule injections at least 90 minutes away from carbohydrate-heavy meals for consistent bioavailability.
  6. Store reconstituted solution under refrigeration (2–8 °C).: Once reconstituted, the protein solution is stable for up to 28 days at refrigerator temperature; discard if the solution appears cloudy or particulate, which may signal degradation or contamination.

Warnings

Contraindications:

Do not use in individuals with active malignancy, diabetic retinopathy, acute critical illness, or known hypersensitivity to somatropin or any excipient. Closed epiphyses are not a contraindication in adults but must be confirmed before use in younger populations.

Side Effects:

Fluid retention in peripheral tissues, reversible joint discomfort, and transient blood glucose elevation are the most commonly reported effects; these are dose-dependent and typically resolve with dose adjustment. Immunogenic reactions — more frequently associated with 192aa or degraded somatropin products than with analytically pure 191aa material — can include injection-site reactions.

Monitoring:

Fasting glucose should be assessed at baseline and periodically during use, particularly at doses above 2 IU/day. IGF-1 serum measurement provides an objective marker of biological response; values significantly above age-adjusted reference ranges suggest dose reduction is warranted. Thyroid function screening is advisable in protocols exceeding 12 weeks.

PCT / Cycle Considerations:

Somatropin does not suppress the hypothalamic-pituitary-gonadal axis directly; standard PCT protocols targeting LH/FSH recovery are therefore not required for somatropin alone. However, when used alongside anabolic agents, complete PCT planning should address the suppressive compounds independently.

Frequently asked questions

What is the structural difference between 191aa and 192aa somatropin, and why does it affect potency?
191aa somatropin replicates the exact 191-residue primary sequence of endogenous human growth hormone, enabling correct protein folding and full GH-receptor binding. The 192aa variant carries an additional N-terminal methionine residue introduced during prokaryotic expression — this alters the molecule's three-dimensional conformation, measurably reduces receptor occupancy efficiency, and raises the probability of anti-somatropin antibody formation with repeated administration.
How does reversed-phase HPLC testing confirm HGH purity, and what impurities does it detect?
Reversed-phase HPLC separates the 22 kDa somatropin isoform from structurally related impurities — including oxidised methionine variants, deamidated species, and aggregated forms — based on differences in hydrophobicity and molecular size. The European Pharmacopoeia somatropin monograph sets a ≤1 % limit for individual impurities; HPLC quantified against a certified reference standard is the method of choice for confirming compliance with that threshold.
What does the LAL endotoxin test measure in an HGH vial, and what is the acceptable limit?
The Limulus Amebocyte Lysate (LAL) test detects bacterial endotoxins — lipopolysaccharide fragments released from gram-negative bacteria during recombinant protein fermentation. For somatropin, the pharmacopoeial endotoxin limit is 5 EU per mg of protein; exceeding this threshold risks pyrogenic reactions upon injection. LAL testing is a mandatory release criterion for pharmaceutical-grade products and should be documented in any batch certificate of analysis.
How should Imperia Laboratories Liquid 50IU be stored once the vial has been reconstituted?
After reconstitution with bacteriostatic water, the vial must be stored upright at 2–8 °C and used within 28 days. Do not freeze the reconstituted solution — ice-crystal formation irreversibly denatures the protein structure and cannot be corrected by re-dissolving. Inspect the solution before each use; any cloudiness, colour change or visible particles indicates degradation and the vial should be discarded.
Can I verify HGH quality myself without lab equipment, or is professional testing required?
Visual inspection and solubility checks are insufficient to confirm 191aa purity or detect low-level impurities — these require analytical instrumentation. Requesting the batch-specific HPLC certificate of analysis and LAL endotoxin report from the supplier is the practical first step for end-users. Community-based third-party peptide testing services (independent laboratories accepting anonymous submissions) can provide mass spectrometry or HPLC confirmation of identity and approximate purity at accessible cost. (2) angle_used

Manufacturer

Imperia Laboratories' approach to its injectable recombinant protein line rests on a supply-chain principle that is categorically different from the logic governing its oral-tablet catalogue: for a lyophilised somatropin product, the critical quality variable is not per-tablet API mass but the molecular integrity of the protein itself — a property determined upstream, at API sourcing, before any formulation step occurs. For Liquid 50IU, the laboratory selects somatropin raw material exclusively from recombinant expression facilities operating within GMP-compliant bioprocess frameworks, requiring incoming certificate of analysis documentation that specifies the amino-acid sequence (191aa), host organism, and purification train used. That incoming material review forms the foundation of the product's analytical traceability: because HPLC purity data and LAL endotoxin results generated at finished-product release are only as meaningful as the starting material they act on, Imperia Laboratories treats API sourcing audit as a release prerequisite rather than a procedural formality.

Product details

BrandImperia Laboratories
Active ingredienthuman growth hormone
Also known asHGH, Somatropin, Wachstumshormon, GH, Liquid 50IU, Imperia Laboratories HGH
Strength50 IU
FormVial
Pack size1 piece
Item numberHGH-HGH-IMP-008

Reviews

5/5

2 reviews

  • Rating: 5 out of 5 starsTroy C.Verified purchase

    Exactly what I needed

    Been using this at 2IU ED for 12 weeks alongside a light test cycle. Bloods came back clean, IGF-1 up noticeably, sleep has been absolutely elite. Skin looking tighter and recovery between sessions is a different world. Packaging was discreet, landed in 6 days. Will reorder without hesitation.

  • Rating: 5 out of 5 starsheavyhitter_15Verified purchase

    Solid HGH, no complaints

    running 3IU ED split AM and post workout. by week 6 joints felt noticeably better, was half-expecting the carpal tunnel tingle and got a mild version of it first two weeks which honestly just confirmed it was legit. weight stayed same but body composition shifted lost maybe 3kg fat, put on lean tissue. Quality product from a quality lab

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Evogene 10iu/vial 10 Vials by AlleyLab Tested

Evogene 10iu/vial 10 Vials by Alley

€260.00
Kigtropin 200 IU 20iu/vial 10 Vials by BiotechnologyHPLC Verified

Kigtropin 200 IU 20iu/vial 10 Vials by Biotechnology

€320.00
NordiTrex 10iu/vial 1 Vial by Concentrex LabsPharma Grade

NordiTrex 10iu/vial 1 Vial by Concentrex Labs

€16.00
Jintropin 120 IU 12iu/vial 10 Vials by GensciPurity Tested

Jintropin 120 IU 12iu/vial 10 Vials by Gensci

€160.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00